The Global Intragastric Balloon Market size was valued at USD 38.56 Million in 2022 and the total Intragastric Balloon revenue is expected to grow at a CAGR of 13.4% from 2023 to 2029, reaching nearly USD 92.99 MillionIntragastric Balloon Market Overview
An intragastric balloon is a medical device designed for weight loss by temporarily altering the stomach's capacity. Typically made of silicone, it is introduced into the stomach through an endoscopic procedure, where it is initially deflated and then filled with either saline solution or gas. Its primary purpose is to induce weight loss by reducing the amount of food an individual consume during a meal due to the balloon occupying space in the stomach, thereby promoting early satiety. Intragastric balloons are commonly recommended for individuals who are obese or significantly overweight and have struggled to achieve substantial weight loss through conventional methods like diet and exercise. They offer a non-surgical approach to weight management, making them less invasive and requiring a shorter recovery period compared to traditional weight loss surgeries like gastric bypass or sleeve gastrectomy. These balloons are typically utilized as part of a broader weight management program, emphasizing lifestyle changes, healthier eating habits, and increased physical activity. While they lead to weight loss and improvements in various obesity-related health conditions, it's important to note that intragastric balloons are considered a short-term solution. They are typically left in the stomach for a period of six months to a year, after which they are removed. During this time, patients are encouraged to make sustainable lifestyle changes to help maintain their weight loss after the balloon is removed. Eligibility for intragastric balloon insertion is determined by healthcare professionals based on factors such as the individual's overall health, weight, and medical history, as it may not be suitable for everyone. In the United States, individuals with a BMI of 30 or higher, who successfully pass the health evaluation for the procedure, are eligible to receive the intragastric balloon. Those with class III obesity, who meet the criteria for bariatric surgery, have the option to opt for the balloon due to its lower associated risks. Additionally, individuals whose obesity poses a safety concern for surgical intervention consider the balloon as an intermediate step to shed sufficient weight, thus making them eligible for surgery.To know about the Research Methodology :- Request Free Sample Report
Intragastric Balloon Market Dynamics
Exploring the Role of Intragastric Balloons in Non-Invasive Obesity Management The increasing prevalence of obesity has become a prominent health concern in recent years, with its detrimental effects on overall well-being and the associated risk of various medical conditions. In response to this growing epidemic, there has been a consistent push in the healthcare industry towards adopting non-invasive methods for obesity management. Among these approaches, intragastric balloons have emerged as a valuable adjunct in the battle against obesity. Intragastric balloons offer a promising solution by providing a less invasive option for weight management. These devices are typically inserted into the stomach through a minimally invasive procedure, offering benefits such as reduced recovery time and a lower risk of complications compared to more invasive surgical options. This non-surgical approach is particularly appealing to individuals who may be hesitant about or ineligible for surgical interventions due to medical conditions or personal preferences.One of the key factors driving the utilization of intragastric balloons is the promising outcomes they offer, especially when used in conjunction with lifestyle modifications and pharmacotherapy. These balloons facilitate portion control by occupying space in the stomach, leading to reduced food intake and a sense of fullness, which aids in weight loss. When combined with dietary changes, regular physical activity, and, if necessary, medication-based therapies, intragastric balloons significantly enhance the effectiveness of obesity management strategies. These aspects drive the intragastric balloon market growth. Constraints and Considerations for Intragastric Balloon Usage Hampered the Intragastric Balloon Market Growth Intragastric balloons offer a non-invasive approach to weight loss, several important considerations act as restraints on their widespread adoption in the weight management market. One significant limitation is their temporary nature. Typically, these balloons are removed after a period ranging from six months to a year, providing only a short-term solution to weight loss. For individuals seeking long-term weight maintenance, additional interventions may be necessary. Moreover, the use of intragastric balloons be accompanied by side effects during the initial weeks after placement, including symptoms like nausea, vomiting, abdominal discomfort, and acid reflux. These side effects are challenging for some patients to tolerate. Weight regain is another concern associated with intragastric balloons. After their removal, maintaining the lost weight requires a commitment to a healthy lifestyle that includes diet and exercise changes. Failure to make these long-term changes results in the reoccurrence of weight issues. Furthermore, while intragastric balloons lead to weight loss, the extent of this loss varies among individuals and may not be as significant as what is achieved with other bariatric surgeries such as gastric bypass or sleeve gastrectomy. Additionally, there is a rare but potential risk of balloon deflation or migration within the stomach, which may necessitate further medical attention or even surgical removal. These factors restrain the growth of the intragastric balloon market. Expanding Horizons is a Key Factor for the Growing Opportunity in the Intragastric Balloon Market Demand The intragastric balloon market presents a significant opportunity in the field of non-surgical weight management, driven by the increasing prevalence of obesity and the growing demand for minimally invasive treatment options. This market is poised for expansion as it addresses key medical, economic, and patient-oriented factors. The rising global obesity epidemic has created a substantial market opportunity for intragastric balloons. As obesity rates continue to soar, healthcare providers and patients alike are seeking effective, less invasive interventions to combat excess weight. Intragastric balloons offer a promising solution, appealing to individuals who may not be candidates for more invasive surgical procedures due to medical contraindications or personal preferences. The economic impact of obesity is substantial, with obesity-related healthcare costs reaching staggering figures. Intragastric balloons provide a cost-effective alternative to long-term obesity management, potentially reducing the burden on healthcare systems by mitigating the need for more costly treatments and interventions associated with obesity-related comorbidities. The intragastric balloon market benefits from its adaptability as a bridging option for individuals who need to lose weight before undergoing other bariatric surgeries, making it a complementary element in the broader field of weight management. Intragastric balloons are not only minimally invasive but also offer relatively short recovery times, making them appealing to patients seeking a quicker return to their daily lives compared to traditional surgical approaches. Their potential for achieving substantial weight loss, when combined with lifestyle modifications, appeals to individuals who desire tangible results. As the market continues to evolve, innovations in balloon design and materials, enhanced patient selection criteria, and improved post-procedural support systems are expected to contribute to the growth of this market. Additionally, the possibility of insurance coverage expansion for intragastric balloon procedures further increases market accessibility. All these aspects boost the market intragastric balloon market demand during the forecast period. The State of Obesity 2022 report highlights a concerning trend where nearly four out of ten American adults are grappling with obesity, and these rates are steadily rising across different demographics. This emphasizes that obesity is a complex issue influenced by a multitude of factors, including societal, biological, genetic, and environmental elements, many of which are beyond an individual's control. According to the report's authors, effectively addressing the obesity crisis will necessitate a focus on economic and structural factors that impact people's living conditions. Intragastric balloons are a valuable tool in the fight against obesity. While the report underscores the multifaceted nature of obesity, intragastric balloons offer a practical solution for individuals struggling with excess weight. These devices provide a non-surgical option for weight loss, which is especially important in a context where obesity rates are on the rise. Intragastric balloons help individuals control their appetite and reduce food intake, serving as an effective tool for weight management. They work by physically occupying space in the stomach, leading to feelings of fullness even with smaller meals. This be particularly beneficial for those facing challenges related to genetic predisposition or environmental factors that contribute to obesity. Moreover, intragastric balloons are a non-invasive approach, which aligns with the recognition in the report that obesity is influenced by societal and structural factors. Individuals who may not have access to or prefer not to undergo traditional weight loss surgeries consider intragastric balloons as a safer and more accessible option.
Intragastric Balloon Market Regional Insights
North America dominates the global intragastric balloon market, with the highest revenue share in 2022. Several factors contribute to this market's growth in the region. The increasing prevalence of obesity is set to be a key driver of growth in the intragastric balloon market in the foreseeable future. For instance, the National Institute of Health (NIH) reports that obesity, along with being overweight, ranks as the second leading cause of preventable deaths in the United States. The surge in the adoption of unhealthy dietary patterns and sedentary lifestyles, characterized by a lack of physical activity, is primarily responsible for the widespread occurrence of obesity on a global scale. Consequently, the escalating instances of obesity exert significant pressure on healthcare resources, ultimately fostering the expansion of the intragastric balloon industry. Furthermore, the increasing awareness surrounding obesity and its associated health complications is poised to have a profound impact on the demand for and adoption of intragastric balloons in the coming years. Many countries are grappling with a substantial rise in the economic burden imposed by this disease. Consequently, numerous nations are taking proactive initiatives to control and manage obesity comprehensively. These efforts contribute to the dissemination of knowledge concerning obesity management and the availability of various weight control alternatives, including intragastric balloons, thus fuelling intragastric balloon market growth throughout the forecast period in North America.Latest Development
In September 2022, for intragastric balloons market witnessed a significant development with the launch of Allurion's innovative swallowable gastric balloon capsule for weight loss in India. This strategic move by Allurion has redefined the competitive landscape in the industry. Allurion's comprehensive weight loss program not only includes the groundbreaking Swallowable Capsule but also integrates a suite of technology-driven solutions designed to enhance the patient experience and outcomes. Allurion introduced its Swallowable Gastric Balloon Capsule for weight loss in the Indian market, marking a pivotal moment in the field of non-surgical weight management. This product launch signifies a bold step in expanding the global footprint of intragastric balloons and reinforces Allurion's commitment to addressing the escalating obesity concerns in India, which is home to one of the world's largest populations. In addition to the innovative Swallowable Capsule, they introduced the Allurion Virtual Care Suite, a cutting-edge remote patient monitoring solution powered by the Allurion Iris AI platform. This suite encompasses a range of digital tools and devices, including the Allurion Mobile App, Connected Scale, and Health Tracker. These components synergize to provide patients with a comprehensive and personalized weight management experience, enabling them to track their progress, receive guidance, and stay connected with healthcare professionals throughout their weight loss journey. The introduction of Allurion's innovative products and services into the Indian market is set to intensify competition in the intragastric balloon sector. It highlights the industry's dedication to innovation and patient-centric care, ultimately providing individuals with a wider array of choices for their weight loss journeys. Allurion's holistic approach may serve as a benchmark for future developments in the field, encouraging further advancements and ensuring that patients have access to more effective and personalized solutions for obesity management for the Intragastric Balloon market demand.Intragastric Balloon Market Scope: Inquiry Before Buying
Intragastric Balloon Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 38.56 Bn. Forecast Period 2023 to 2029 CAGR: 13.4% Market Size in 2029: US $ 92.99 Bn. Segments Covered: by Product Single Balloon Dual Balloon by Filling Material Saline-Filled Gas-Filled by End-Use Hospitals Ambulatory Surgical Centers Intragastric Balloon Market Regional Insights:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Intragastric Balloon Market Key Players:
1. Obalon Therapeutics (U.S.) 2. Apollo Endosurgery Inc. (U.S.) 3. Allurion (U.S.) 4. Spatz3 (U.S.) 5. ReShape Lifesciences Inc.v (U.S.) 6. Helioscopie (France) 7. Apollo Endosurgery, Inc. (U.S.) 8. Obalon Therapeutics, Inc. (U.S.) 9. Endalis (France) 10. Lexel Medical (U.S.) 11. Districlass Medical (France) 12. Shandong Institute of Medical Instruments (China) 13. Phagia Technologies, Inc. (U.S.) 14. Fengh Medical B.V. (China) 15. Medicone Group (U.S.) 16. BAROnova Inc. (U.K.)FAQs:
1. What are the growth drivers for the Intragastric Balloon Market? Ans. The increasing prevalence of obesity, compounded by unhealthy lifestyles, is a primary growth driver for the Intragastric Balloon Market. Growing awareness of obesity-related health risks and rising healthcare costs are boosting demand for non-invasive weight management solutions. Additionally, Innovations in intragastric balloon technology and comprehensive patient support systems are enhancing market prospects by improving effectiveness and patient experience. 2. What is the major Opportunity for the Intragastric Balloon Market growth? Ans. The Intragastric Balloon Market is poised for growth due to increasing obesity rates and the demand for non-surgical weight management solutions. Innovations in balloon technology, improved patient support systems, and expanded insurance coverage present significant growth opportunities.The market also benefits from a growing awareness of obesity-related health issues, driving demand for effective and minimally invasive interventions. 3. Which Region is expected to lead the global Intragastric Balloon Market during the forecast period? Ans. North America is expected to lead the Intragastric Balloon Market during the forecast period. 4. What is the projected market size and growth rate of the Intragastric Balloon Market? Ans. The Intragastric Balloon Market size was valued at USD 38.56 Million in 2022 and the total Intragastric Balloon Market revenue is expected to grow at a CAGR of 13.4% from 2023 to 2029, reaching nearly USD 92.99 Million. 5. What segments are covered in the Intragastric Balloon Market report? Ans. The segments covered in the Intragastric Balloon Market report are Product, Filling Material, End-Use, and region.
1. Intragastric Balloon Market: Research Methodology 2. Intragastric Balloon Market Introduction 2.1 Study Assumption and Market Definition 2.2 Scope of the Study 2.3 Executive Summary 3. Intragastric Balloon Market: Dynamics 3.1 Intragastric Balloon Market Trends by Region 3.1.1 Global Intragastric Balloon Market Trends 3.1.2 North America Intragastric Balloon Market Trends 3.1.3 Europe Intragastric Balloon Market Trends 3.1.4 Asia Pacific Intragastric Balloon Market Trends 3.1.5 Middle East and Africa Intragastric Balloon Market Trends 3.1.6 South America Intragastric Balloon Market Trends 3.2 Intragastric Balloon Market Dynamics by Region 3.2.1 North America 3.2.1.1 North America Intragastric Balloon Market Drivers 3.2.1.2 North America Intragastric Balloon Market Restraints 3.2.1.3 North America Intragastric Balloon Market Opportunities 3.2.1.4 North America Intragastric Balloon Market Challenges 3.2.2 Europe 3.2.2.1 Europe Intragastric Balloon Market Drivers 3.2.2.2 Europe Intragastric Balloon Market Restraints 3.2.2.3 Europe Intragastric Balloon Market Opportunities 3.2.2.4 Europe Intragastric Balloon Market Challenges 3.2.3 Asia Pacific 3.2.3.1 Asia Pacific Intragastric Balloon Market Market Drivers 3.2.3.2 Asia Pacific Intragastric Balloon Market Restraints 3.2.3.3 Asia Pacific Intragastric Balloon Market Opportunities 3.2.3.4 Asia Pacific Intragastric Balloon Market Challenges 3.2.4 Middle East and Africa 3.2.4.1 Middle East and Africa Intragastric Balloon Market Drivers 3.2.4.2 Middle East and Africa Intragastric Balloon Market Restraints 3.2.4.3 Middle East and Africa Intragastric Balloon Market Opportunities 3.2.4.4 Middle East and Africa Intragastric Balloon Market Challenges 3.2.5 South America 3.2.5.1 South America Intragastric Balloon Market Drivers 3.2.5.2 South America Intragastric Balloon Market Restraints 3.2.5.3 South America Intragastric Balloon Market Opportunities 3.2.5.4 South America Intragastric Balloon Market Challenges 3.3 PORTER’s Five Forces Analysis 3.3.1 Bargaining Power Of Suppliers 3.3.2 Bargaining Power Of Buyers 3.3.3 Threat Of New Entrants 3.3.4 Threat Of Substitutes 3.3.5 Intensity Of Rivalry 3.4 PESTLE Analysis 3.5 Value Chain Analysis 3.6 Regulatory Landscape by Region 3.6.1 Global 3.6.2 North America 3.6.3 Europe 3.6.4 Asia Pacific 3.6.5 Middle East and Africa 3.6.6 South America 3.7 Analysis of Government Schemes and Initiatives for the Intragastric Balloon Industry 3.8 The Global Pandemic and Redefining of The Intragastric Balloon Industry Landscape 3.9 Price Trend Analysis 3.10 Technological Road Map 3.11 Global Intragastric Balloon Trade Analysis (2017-2022) 3.11.1 Global Import of Intragastric Balloon 3.11.2 Global Export of Intragastric Balloon 3.12 Global Intragastric Balloon Production Capacity Analysis 3.12.1 Chapter Overview 3.12.2 Key Assumptions and Methodology 3.12.3 Analysis by Size of Manufacturer 4. Global Intragastric Balloon Market: Global Market Size and Forecast by Segmentation for Demand and Supply Side (Value) (2022-2029) 4.1 Global Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 4.1.1 Single Balloon 4.1.2 Dual Balloon 4.2 Global Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 4.2.1 Saline-Filled 4.2.2 Gas-Filled 4.3 Global Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 4.3.1 Hospitals 4.3.2 Ambulatory Surgical Centers 4.4 Global Intragastric Balloon Market Size and Forecast, by Region (2022-2029) 4.4.1 North America 4.4.2 Europe 4.4.3 Asia Pacific 4.4.4 Middle East and Africa 4.4.5 South America 5. North America Intragastric Balloon Market Size and Forecast by Segmentation for Demand and Supply Side (Value) (2022-2029) 5.1 North America Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 5.1.1 Single Balloon 5.1.2 Dual Balloon 5.2 North America Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 5.2.1 Saline-Filled 5.2.2 Gas-Filled 5.3 North America Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 5.3.1 Hospitals 5.3.2 Ambulatory Surgical Centers 5.4 North America Intragastric Balloon Market Size and Forecast, by Country (2022-2029) 5.4.1 United States 5.4.1.1 United States Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 5.4.1.1.1 Single Balloon 5.4.1.1.2 Dual Balloon 5.4.1.2 United States Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 5.4.1.2.1 Saline-Filled 5.4.1.2.2 Gas-Filled 5.4.1.3 United States Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 5.4.1.3.1 Hospitals 5.4.1.3.2 Ambulatory Surgical Centers 5.4.2 Canada 5.4.2.1 Canada Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 5.4.2.1.1 Single Balloon 5.4.2.1.2 Dual Balloon 5.4.2.2 Canada Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 5.4.2.2.1 Saline-Filled 5.4.2.2.2 Gas-Filled 5.4.2.3 Canada Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 5.4.2.3.1 Hospitals 5.4.2.3.2 Ambulatory Surgical Centers 5.4.3 Mexico 5.4.3.1 Mexico Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 5.4.3.1.1 Single Balloon 5.4.3.1.2 Dual Balloon 5.4.3.2 Mexico Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 5.4.3.2.1 Saline-Filled 5.4.3.2.2 Gas-Filled 5.4.3.3 Mexico Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 5.4.3.3.1 Hospitals 5.4.3.3.2 Ambulatory Surgical Centers 6. Europe Intragastric Balloon Market Size and Forecast by Segmentation for Demand and Supply Side (Value) (2022-2029) 6.1 Europe Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 6.2 Europe Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 6.3 Europe Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 6.4 Europe Intragastric Balloon Market Size and Forecast, by Country (2022-2029) 6.4.1 United Kingdom 6.4.1.1 United Kingdom Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 6.4.1.2 United Kingdom Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 6.4.1.3 United Kingdom Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 6.4.2 France 6.4.2.1 France Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 6.4.2.2 France Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 6.4.2.3 France Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 6.4.3 Germany 6.4.3.1 Germany Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 6.4.3.2 Germany Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 6.4.3.3 Germany Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 6.4.4 Italy 6.4.4.1 Italy Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 6.4.4.2 Italy Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 6.4.4.3 Italy Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 6.4.5 Spain 6.4.5.1 Spain Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 6.4.5.2 Spain Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 6.4.5.3 Spain Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 6.4.6 Sweden 6.4.6.1 Sweden Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 6.4.6.2 Sweden Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 6.4.6.3 Sweden Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 6.4.7 Austria 6.4.7.1 Austria Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 6.4.7.2 Austria Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 6.4.7.3 Austria Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 6.4.8 Rest of Europe 6.4.8.1 Rest of Europe Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 6.4.8.2 Rest of Europe Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029). 6.4.8.3 Rest of Europe Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7. Asia Pacific Intragastric Balloon Market Size and Forecast by Segmentation for Demand and Supply Side (Value) (2022-2029) 7.1 Asia Pacific Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.2 Asia Pacific Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.3 Asia Pacific Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4 Asia Pacific Intragastric Balloon Market Size and Forecast, by Country (2022-2029) 7.4.1 China 7.4.1.1 China Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.1.2 China Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.1.3 China Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.2 South Korea 7.4.2.1 S Korea Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.2.2 S Korea Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.2.3 S Korea Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.3 Japan 7.4.3.1 Japan Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.3.2 Japan Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.3.3 Japan Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.4 India 7.4.4.1 India Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.4.2 India Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.4.3 India Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.5 Australia 7.4.5.1 Australia Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.5.2 Australia Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.5.3 Australia Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.6 Indonesia 7.4.6.1 Indonesia Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.6.2 Indonesia Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.6.3 Indonesia Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.7 Malaysia 7.4.7.1 Malaysia Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.7.2 Malaysia Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.7.3 Malaysia Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.8 Vietnam 7.4.8.1 Vietnam Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.8.2 Vietnam Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.8.3 Vietnam Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.9 Taiwan 7.4.9.1 Taiwan Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.9.2 Taiwan Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.9.3 Taiwan Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.10 Bangladesh 7.4.10.1 Bangladesh Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.10.2 Bangladesh Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.10.3 Bangladesh Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.11 Pakistan 7.4.11.1 Pakistan Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.11.2 Pakistan Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.11.3 Pakistan Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 7.4.12 Rest of Asia Pacific 7.4.12.1 Rest of Asia Pacific Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 7.4.12.2 Rest of Asia Pacific Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 7.4.12.3 Rest of Asia Pacific Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 8. Middle East and Africa Intragastric Balloon Market Size and Forecast by Segmentation for Demand and Supply Side (Value) (2022-2029) 8.1 Middle East and Africa Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 8.2 Middle East and Africa Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 8.3 Middle East and Africa Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 8.4 Middle East and Africa Intragastric Balloon Market Size and Forecast, by Country (2022-2029) 8.4.1 South Africa 8.4.1.1 South Africa Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 8.4.1.2 South Africa Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 8.4.1.3 South Africa Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 8.4.2 GCC 8.4.2.1 GCC Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 8.4.2.2 GCC Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 8.4.2.3 GCC Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 8.4.3 Egypt 8.4.3.1 Egypt Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 8.4.3.2 Egypt Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 8.4.3.3 Egypt Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 8.4.4 Nigeria 8.4.4.1 Nigeria Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 8.4.4.2 Nigeria Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 8.4.4.3 Nigeria Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 8.4.5 Rest of ME&A 8.4.5.1 Rest of ME&A Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 8.4.5.2 Rest of ME&A Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 8.4.5.3 Rest of ME&A Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 9. South America Intragastric Balloon Market Size and Forecast by Segmentation for Demand and Supply Side (Value) (2022-2029) 9.1 South America Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 9.2 South America Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 9.3 South America Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 9.4 South America Intragastric Balloon Market Size and Forecast, by Country (2022-2029) 9.4.1 Brazil 9.4.1.1 Brazil Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 9.4.1.2 Brazil Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 9.4.1.3 Brazil Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 9.4.2 Argentina 9.4.2.1 Argentina Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 9.4.2.2 Argentina Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 9.4.2.3 Argentina Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 9.4.3 Rest Of South America 9.4.3.1 Rest Of South America Intragastric Balloon Market Size and Forecast, By Product (2022-2029) 9.4.3.2 Rest Of South America Intragastric Balloon Market Size and Forecast, By Filling Material (2022-2029) 9.4.3.3 Rest Of South America Intragastric Balloon Market Size and Forecast, By End-Use (2022-2029) 10. Global Intragastric Balloon Market: Competitive Landscape 10.1 MMR Competition Matrix 10.2 Competitive Landscape 10.3 Key Players Benchmarking 10.3.1 Company Name 10.3.2 Product Segment 10.3.3 End-user Segment 10.3.4 Revenue (2022) 10.3.5 Manufacturing Locations 10.3.6 SKU Details 10.3.7 Production Capacity 10.3.8 Production for 2022 10.4 Market Analysis by Organized Players vs. Unorganized Players 10.4.1 Organized Players 10.4.2 Unorganized Players 10.5 Leading Intragastric Balloon Global Companies, by market capitalization 10.6 Market Structure 10.6.1 Market Leaders 10.6.2 Market Followers 10.6.3 Emerging Players 10.7 Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1 Apollo Endosurgery, Inc. (U.S.) 11.1.1 Company Overview 11.1.2 Business Portfolio 11.1.3 Financial Overview 11.1.4 SWOT Analysis 11.1.5 Strategic Analysis 11.1.6 Scale of Operation (small, medium, and large) 11.1.7 Details on Partnership 11.1.8 Regulatory Accreditations and Certifications Received by Them 11.1.9 Awards Received by the Firm 11.1.10 Recent Developments 11.2 Obalon Therapeutics (U.S.) 11.3 Allurion (U.S.) 11.4 Spatz3 (U.S.) 11.5 ReShape Lifesciences Inc. (U.S.) 11.6 Helioscopie (France) 11.7 Endalis (France) 11.8 Lexel Medical (U.S.) 11.9 Districlass Medical (France) 11.10 Shandong Institute of Medical Instruments (China) 11.11 Phagia Technologies, Inc. (U.S.) 11.12 Fengh Medical B.V. (China) 11.13 Medicone Group (U.S.) 11.14 BAROnova Inc. (U.K.) 12. Key Findings 13. Industry Recommendations 14. Terms and Glossary